Central corneal thickness in glaucoma patients lower with use of prostaglandins

ORLANDO, Fla. — Central corneal thickness was reduced in glaucomatous eyes treated with prostaglandins alone or with combined beta blockers, prostaglandins and carbonic anhydrase inhibitors, according to a poster presented here at the Association for Research in Vision and Ophthalmology meeting. A total of 405 eyes with ocular hypertension, suspected glaucoma, perimetric glaucoma or no glaucoma were followed with standard automated perimetry, 24-hour IOP profile, optic disc photography and optical coherence pachymetry (Heidelberg Engineering) in a trial evaluating diagnostic and prognostic validity of morphometric, sensory and hemodynamic diagnostic procedures in (Read more...)

Full Story →